Quarterly report pursuant to Section 13 or 15(d)

Acquisitions - Schedule of Intangible Assets Acquired (Details)

v3.19.1
Acquisitions - Schedule of Intangible Assets Acquired (Details) - USD ($)
 3 Months Ended 10 Months Ended
Feb. 16, 2018
Nov. 17, 2017
Jun. 30, 2018
Sep. 30, 2018
Avadel        
Business Acquisition [Line Items]        
Identifiable Intangible Assets: $ 18,291,000      
Intangible assets     $ 1,838,000  
TRx        
Business Acquisition [Line Items]        
Identifiable Intangible Assets:   $ 19,596,000    
Intangible assets       $ 1,528,000
PAI sales and marketing agreement | TRx        
Business Acquisition [Line Items]        
Identifiable Intangible Assets:   $ 2,553,000    
Intangible assets       219,000
Acquired finite-lived intangible assets, weighted average useful life (in years)   2 years    
Karbinal | Acquired product marketing rights | Avadel        
Business Acquisition [Line Items]        
Identifiable Intangible Assets: $ 6,200,000      
Intangible assets     (21,000)  
Acquired finite-lived intangible assets, weighted average useful life (in years) 10 years      
AcipHex | Acquired product marketing rights | Avadel        
Business Acquisition [Line Items]        
Identifiable Intangible Assets: $ 2,803,000      
Intangible assets     283,000  
Acquired finite-lived intangible assets, weighted average useful life (in years) 10 years      
Cefaclor | Acquired product marketing rights | Avadel        
Business Acquisition [Line Items]        
Identifiable Intangible Assets: $ 7,611,000      
Intangible assets     1,320,000  
Acquired finite-lived intangible assets, weighted average useful life (in years) 7 years      
Flexichamber | Acquired Developed Technology | Avadel        
Business Acquisition [Line Items]        
Identifiable Intangible Assets: $ 1,677,000      
Intangible assets     546,000  
Acquired finite-lived intangible assets, weighted average useful life (in years) 10 years      
LiquiTime Process | In Process Research and Development | Avadel        
Business Acquisition [Line Items]        
Identifiable Intangible Assets: $ 0      
Intangible assets     $ (290,000)  
Metafolin | Acquired product marketing rights | TRx        
Business Acquisition [Line Items]        
Identifiable Intangible Assets:   $ 11,987,000    
Intangible assets       1,522,000
Acquired finite-lived intangible assets, weighted average useful life (in years)   15 years    
Millipred | Acquired product marketing rights | TRx        
Business Acquisition [Line Items]        
Identifiable Intangible Assets:   $ 5,056,000    
Intangible assets       342,000
Acquired finite-lived intangible assets, weighted average useful life (in years)   4 years    
Ulesfia | Acquired product marketing rights | TRx        
Business Acquisition [Line Items]        
Identifiable Intangible Assets:   $ 0    
Intangible assets       $ (555,000)
Previously Reported | Avadel        
Business Acquisition [Line Items]        
Identifiable Intangible Assets: 16,453,000      
Previously Reported | TRx        
Business Acquisition [Line Items]        
Identifiable Intangible Assets:   18,068,000    
Previously Reported | PAI sales and marketing agreement | TRx        
Business Acquisition [Line Items]        
Identifiable Intangible Assets:   2,334,000    
Previously Reported | Karbinal | Acquired product marketing rights | Avadel        
Business Acquisition [Line Items]        
Identifiable Intangible Assets: 6,221,000      
Previously Reported | AcipHex | Acquired product marketing rights | Avadel        
Business Acquisition [Line Items]        
Identifiable Intangible Assets: 2,520,000      
Previously Reported | Cefaclor | Acquired product marketing rights | Avadel        
Business Acquisition [Line Items]        
Identifiable Intangible Assets: 6,291,000      
Previously Reported | Flexichamber | Acquired Developed Technology | Avadel        
Business Acquisition [Line Items]        
Identifiable Intangible Assets: 1,131,000      
Previously Reported | LiquiTime Process | In Process Research and Development | Avadel        
Business Acquisition [Line Items]        
Identifiable Intangible Assets: $ 290,000      
Previously Reported | Metafolin | Acquired product marketing rights | TRx        
Business Acquisition [Line Items]        
Identifiable Intangible Assets:   10,465,000    
Previously Reported | Millipred | Acquired product marketing rights | TRx        
Business Acquisition [Line Items]        
Identifiable Intangible Assets:   4,714,000    
Previously Reported | Ulesfia | Acquired product marketing rights | TRx        
Business Acquisition [Line Items]        
Identifiable Intangible Assets:   $ 555,000